Trinity Street Asset Management LLP Sells 3,292 Shares of Cigna Group $CI

Trinity Street Asset Management LLP lowered its position in Cigna Group (NYSE:CI) by 4.4% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 71,012 shares of the health services provider’s stock after selling 3,292 shares during the quarter. Cigna Group accounts for 1.0% of Trinity Street Asset Management LLP’s holdings, making the stock its 20th largest position. Trinity Street Asset Management LLP’s holdings in Cigna Group were worth $19,577,000 as of its most recent SEC filing.

A number of other large investors have also added to or reduced their stakes in CI. Wilkerson Advisory Group LLC acquired a new position in shares of Cigna Group during the fourth quarter worth $25,000. Kemnay Advisory Services Inc. bought a new position in Cigna Group during the 4th quarter worth $29,000. Prosperity Bancshares Inc bought a new position in Cigna Group during the 4th quarter worth $29,000. Cedar Mountain Advisors LLC increased its stake in shares of Cigna Group by 161.9% in the first quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after buying an additional 68 shares during the period. Finally, Creative Financial Designs Inc. ADV raised its position in shares of Cigna Group by 147.3% during the fourth quarter. Creative Financial Designs Inc. ADV now owns 136 shares of the health services provider’s stock worth $37,000 after acquiring an additional 81 shares during the last quarter. Institutional investors own 86.99% of the company’s stock.

Insider Transactions at Cigna Group

In other Cigna Group news, CAO Jamie G. Kates sold 899 shares of the firm’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This trade represents a 27.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Nicole S. Jones sold 19,436 shares of the business’s stock in a transaction that occurred on Tuesday, August 4th. The shares were sold at an average price of $276.27, for a total value of $5,369,583.72. Following the sale, the insider owned 27,256 shares of the company’s stock, valued at approximately $7,530,015.12. This represents a 41.63% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders own 0.60% of the company’s stock.

Cigna Group Stock Up 1.4%

Cigna Group stock opened at $277.57 on Thursday. The company has a quick ratio of 0.76, a current ratio of 0.76 and a debt-to-equity ratio of 0.68. Cigna Group has a 12-month low of $239.51 and a 12-month high of $315.47. The firm’s fifty day moving average is $286.23 and its 200 day moving average is $281.28. The company has a market capitalization of $73.35 billion, a PE ratio of 11.48, a PEG ratio of 0.94 and a beta of 0.29.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.18. Cigna Group had a net margin of 2.27% and a return on equity of 19.75%. The business had revenue of $70.04 billion for the quarter, compared to analyst estimates of $70.14 billion. During the same period in the prior year, the firm earned $7.20 earnings per share. Cigna Group’s revenue was up 6.7% on a year-over-year basis. Cigna Group has set its FY 2026 guidance at 30.450- EPS. As a group, sell-side analysts predict that Cigna Group will post 30.51 EPS for the current fiscal year.

Cigna Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Tuesday, September 8th will be paid a $1.56 dividend. The ex-dividend date is Tuesday, September 8th. This represents a $6.24 annualized dividend and a dividend yield of 2.2%. Cigna Group’s dividend payout ratio (DPR) is currently 25.82%.

Analysts Set New Price Targets

Several brokerages recently commented on CI. Morgan Stanley upped their target price on Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a report on Wednesday, May 20th. Wolfe Research reaffirmed an “outperform” rating and issued a $315.00 price objective on shares of Cigna Group in a research note on Tuesday, June 16th. Jefferies Financial Group cut shares of Cigna Group from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $336.00 to $307.00 in a research report on Tuesday, August 4th. Mizuho lifted their target price on shares of Cigna Group from $330.00 to $340.00 and gave the stock an “outperform” rating in a research note on Monday, June 8th. Finally, Guggenheim upped their target price on Cigna Group from $338.00 to $361.00 and gave the company a “buy” rating in a research report on Friday, July 31st. Fifteen equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $339.45.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.